JP2005509615A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005509615A5 JP2005509615A5 JP2003535711A JP2003535711A JP2005509615A5 JP 2005509615 A5 JP2005509615 A5 JP 2005509615A5 JP 2003535711 A JP2003535711 A JP 2003535711A JP 2003535711 A JP2003535711 A JP 2003535711A JP 2005509615 A5 JP2005509615 A5 JP 2005509615A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- ester
- mammalian subject
- compound according
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 12
- 208000035143 Bacterial infection Diseases 0.000 claims 4
- 206010017533 Fungal infection Diseases 0.000 claims 4
- 208000031888 Mycoses Diseases 0.000 claims 4
- 208000036142 Viral infection Diseases 0.000 claims 4
- 230000000844 anti-bacterial effect Effects 0.000 claims 4
- 230000000843 anti-fungal effect Effects 0.000 claims 4
- 230000000884 anti-protozoa Effects 0.000 claims 4
- 230000000840 anti-viral effect Effects 0.000 claims 4
- 229940121375 antifungal agent Drugs 0.000 claims 4
- 230000001580 bacterial effect Effects 0.000 claims 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims 4
- 230000002538 fungal effect Effects 0.000 claims 4
- 230000001717 pathogenic effect Effects 0.000 claims 4
- 208000028172 protozoa infectious disease Diseases 0.000 claims 4
- 230000003612 virological effect Effects 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 230000000259 anti-tumor effect Effects 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 239000012678 infectious agent Substances 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/977,478 US7138531B2 (en) | 2001-10-15 | 2001-10-15 | Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| PCT/US2002/032817 WO2003032905A2 (en) | 2001-10-15 | 2002-10-15 | Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005509615A JP2005509615A (ja) | 2005-04-14 |
| JP2005509615A5 true JP2005509615A5 (enExample) | 2006-01-05 |
| JP4504018B2 JP4504018B2 (ja) | 2010-07-14 |
Family
ID=25525177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003535711A Expired - Fee Related JP4504018B2 (ja) | 2001-10-15 | 2002-10-15 | 抗菌及び細胞増殖抑制活性を有する炭水化物ベースの二環式環構造の製造及び使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7138531B2 (enExample) |
| EP (3) | EP1446391A4 (enExample) |
| JP (1) | JP4504018B2 (enExample) |
| AU (1) | AU2002335813A1 (enExample) |
| CA (2) | CA2684419A1 (enExample) |
| WO (1) | WO2003032905A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7101908B2 (en) * | 2001-10-15 | 2006-09-05 | Kemin Pharma Europe B.V.B.A. | Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
| AU2002950657A0 (en) * | 2002-08-08 | 2002-09-12 | Alchemia Limited | Derivatives of monosaccharides for drug discovery |
| AU2002951995A0 (en) * | 2002-10-11 | 2002-10-31 | Alchemia Limited | Classes of compounds that interact with gpcrs |
| CN100347184C (zh) * | 2003-01-07 | 2007-11-07 | 凯敏制药欧洲股份有限公司 | 可用于治疗由黄病毒科病毒如丙型肝炎及牛病毒性腹泻病毒引起的感染的双环糖类化合物 |
| US7125854B2 (en) * | 2003-01-07 | 2006-10-24 | Kemin Pharma B.V.B.A. | Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| WO2009055779A1 (en) * | 2007-10-26 | 2009-04-30 | Redox Pharmaceutical Corporation | A method for reversal of bacterial resistance to metallo-b-lactamase antibiotics and vancomycin |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116821A (en) * | 1990-11-20 | 1992-05-26 | The Procter & Gamble Company | Sulfated glyceroglucolipids as inhibitors of bacterial adherence |
| US5212075A (en) * | 1991-04-15 | 1993-05-18 | The Regents Of The University Of California | Compositions and methods for introducing effectors to pathogens and cells |
| EP0524439A1 (en) * | 1991-07-24 | 1993-01-27 | F.Hoffmann-La Roche & Co. Aktiengesellschaft | Novel cyclohexane and tetrahydropyran derivatives and antifungal compositions containing these derivatives |
| NL9300058A (nl) * | 1992-06-18 | 1994-01-17 | Stichting Rega V Z W | 1,5-anhydrohexitol nucleoside analoga en farmaceutisch gebruik daarvan. |
| EP0601417A3 (de) * | 1992-12-11 | 1998-07-01 | Hoechst Aktiengesellschaft | Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung |
| US5627194A (en) * | 1993-11-17 | 1997-05-06 | Allelix Biopharmaceuticals Inc. | Anti-viral guanidino-substituted compounds |
| JPH07238080A (ja) * | 1994-02-25 | 1995-09-12 | Sagami Chem Res Center | ４−（１，２−ジヒドロキシ−３−ブテニル）−１，３−ジオキサン誘導体 |
| JPH0881490A (ja) * | 1994-09-12 | 1996-03-26 | Sagami Chem Res Center | ３−ｏ−（３−ｏ−カルバモイルマンノピラノシル）ヘプテノール誘導体、及びマンノグロース誘導体の製造法 |
| JP2000507246A (ja) * | 1996-03-21 | 2000-06-13 | トランセル テクノロジーズ インク． | 固体相のリポグリコペプチドライブラリー、組成物及び方法 |
| FR2751334B1 (fr) * | 1996-07-19 | 1998-10-16 | Sanofi Sa | Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2802536B1 (fr) * | 1999-11-23 | 2003-06-13 | Chru Lille | Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections |
| KR100464917B1 (ko) * | 2001-09-25 | 2005-01-06 | 정재민 | 간 기능 영상화를 위한 디설파이드 환원형 갈락토즈 결합혈청알부민 및 이를 포함한 방사성 동위원소 표지 화합물 |
| AUPS143402A0 (en) | 2002-03-28 | 2002-05-09 | Alchemia Pty Ltd | Anomeric derivatives of monosaccharides |
| AU2002950657A0 (en) | 2002-08-08 | 2002-09-12 | Alchemia Limited | Derivatives of monosaccharides for drug discovery |
-
2001
- 2001-10-15 US US09/977,478 patent/US7138531B2/en not_active Expired - Fee Related
-
2002
- 2002-10-15 EP EP02770578A patent/EP1446391A4/en not_active Withdrawn
- 2002-10-15 AU AU2002335813A patent/AU2002335813A1/en not_active Abandoned
- 2002-10-15 CA CA002684419A patent/CA2684419A1/en not_active Abandoned
- 2002-10-15 EP EP10185546A patent/EP2361920A3/en not_active Withdrawn
- 2002-10-15 WO PCT/US2002/032817 patent/WO2003032905A2/en not_active Ceased
- 2002-10-15 CA CA2463084A patent/CA2463084C/en not_active Expired - Fee Related
- 2002-10-15 JP JP2003535711A patent/JP4504018B2/ja not_active Expired - Fee Related
- 2002-10-15 EP EP09160439A patent/EP2168972A3/en not_active Withdrawn
-
2004
- 2004-06-04 US US10/861,768 patent/US7534871B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010530881A5 (enExample) | ||
| JP2005523922A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| JP2004509061A5 (enExample) | ||
| JP2009535352A5 (enExample) | ||
| JP2009536660A5 (enExample) | ||
| JP2005539088A5 (enExample) | ||
| JP2010530372A5 (enExample) | ||
| JP2004506740A5 (enExample) | ||
| JP2007501809A5 (enExample) | ||
| JP2008523098A5 (enExample) | ||
| JP2009507909A5 (enExample) | ||
| JP2001525359A5 (enExample) | ||
| JP2006514012A5 (enExample) | ||
| CA2381097A1 (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents | |
| WO2005084192A3 (en) | Novel 2’-c-methyl nucleoside derivatives | |
| JP2019526596A5 (enExample) | ||
| JP2003503449A5 (enExample) | ||
| JP2011529071A5 (enExample) | ||
| JP2002510633A5 (enExample) | ||
| JP2008518890A5 (enExample) | ||
| JP2003532640A5 (enExample) | ||
| JP2005508955A5 (enExample) | ||
| JP2009500423A5 (enExample) | ||
| JP2002525323A5 (enExample) |